Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06376591
Other study ID # LUMHS/B12/Temp/12.04.2024
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 22, 2024
Est. completion date August 31, 2024

Study information

Verified date April 2024
Source Liaquat University of Medical & Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Vitamin B12, a vital nutrient, plays a crucial role in red blood cell formation, neurological function, and DNA synthesis. Deficiency in B12 can lead to anemia, neurological symptoms such as tingling or numbness, and cognitive impairment. Oral B12 supplementation serves as an effective strategy to address B12 deficiency, especially for individuals with limited dietary intake or absorption issues. Regular B12 supplementation can help restore body B12 levels, alleviate deficiency-related symptoms, and support overall health and well-being.


Description:

The carrier system in oral vitamin B12 supplements plays a pivotal role in ensuring the stability and efficacy of the supplement. It helps protect the vitamin from degradation in the acidic environment of the stomach, enhancing its bioavailability. Additionally, the carrier system facilitates the transport of vitamin B12 across the gastrointestinal tract, promoting optimal absorption. By optimizing the delivery of B12 to the small intestine, the carrier system maximizes its potential for absorption into the bloodstream. Overall, the choice of carrier system significantly impacts the effectiveness of oral B12 supplementation in addressing deficiency and improving health outcomes. Limited research exists regarding the exploration of various carrier systems used in oral B12 supplementation. This gap hinders a comprehensive understanding of how different carriers affect B12 absorption and efficacy. Further studies are needed to elucidate the optimal carrier system for maximizing B12 bioavailability and improving clinical outcomes. Expanding research in this area can enhance our knowledge and guide the development of more effective oral B12 supplements. This study aims to compare the efficacy of sucrosomial and non-sucrosomial carrier systems in delivering vitamin B12 orally. By assessing absorption kinetics and clinical outcomes, we seek to determine the superiority of the sucrosomial carrier system in enhancing B12 bioavailability. Insights from this research could help in the development of more effective oral B12 supplements.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date August 31, 2024
Est. primary completion date July 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Healthy adults, male or female, Aged 18 to 45 years - Stable medical conditions, including stable cardiovascular, renal, hepatic, and hematological status, - Normal vital signs - Weight 60 and 100 kg, Body mass index (BMI) 18-30 kg/m2 - Suboptimal vitamin B12 status, defined as serum B12 levels within the lower end of the reference range established by the laboratory conducting the assay. - Willing and able to provide informed written consent. - Able to comply with study procedures and follow-up visits as outlined in the protocol. Exclusion Criteria: - Known hypersensitivity or allergy to vitamin B12 or any of its components - Known history of cobalt allergy or sensitivity. - Severe malabsorption syndromes, including pernicious anemia or intestinal disorders affecting vitamin B12 absorption - History of gastric bypass surgery or other procedures that significantly alter gastrointestinal anatomy or function - Significant renal impairment (eGFR < 30 mL/min/1.73m²) or hepatic impairment - Cancer - Uncontrolled or significant cardiovascular disease, including recent myocardial infarction, unstable angina, or heart failure - History of psychiatric illness or cognitive impairment that may impair their ability to comply with study procedures or provide informed consent - Currently enrolled in another clinical trial involving investigational products or interventions. - Pregnant or breast-feeding women - Current use of acetaminophen, or nonsteroidal anti-inflammatory drugs, antibiotics, antacids, PPIs, multivitamins, or nutritional supplements with Vit B12 - Any other medical condition or circumstance that, in the investigator's judgment, would compromise the safety of the participant or the integrity of the study

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Oral Vitamin B12 supplement
Oral Vitamin B12
Other:
Control group
No B12 intervention

Locations

Country Name City State
Pakistan Liaquat University of Medical and Health Sciences Jamshoro

Sponsors (1)

Lead Sponsor Collaborator
Liaquat University of Medical & Health Sciences

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Supplementation effect on circulatory vitamin B12 levels Changes in participants serum vitamin B12 levels one-week
Secondary Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability) Any changes in participant's liver function tests (serum levels of Alanine Aminotransferase, Aspartate Aminotransferase, and Alkaline Phosphatase enzymes) one-week
Secondary Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability) Any changes in participant's Kidney function tests (serum levels of creatinine, urea and blood urea nitrogen) one-week
Secondary Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability) Any changes in participant's full blood count one-week
See also
  Status Clinical Trial Phase
Recruiting NCT06100146 - Effectiveness of Fortification With Folic Acid and Vitamin B12 Among Teenage Girls N/A
Completed NCT04083560 - A Comparison of Two Different Doses of Maternal B12 Supplementation in Improving Infant B12 Deficiency and Neurodevelopment N/A
Completed NCT04632771 - Nutritional Status and Bouillon Use in Northern Ghana
Active, not recruiting NCT03853304 - Quadruple Fortified Salt Trial in India N/A
Completed NCT03437824 - Effects of Vitamin B12 Treatment in Singers Early Phase 1
Active, not recruiting NCT05315843 - Cobalamin Supply and Metabolism in Healthy Children From Birth to the Age of 12 Months and in Their Mothers (Cbl_Neo)
Completed NCT05614960 - Dried Purple Laver (Nori) as a Food Source of Vitamin B12 in Vegetarians N/A
Completed NCT03444155 - Natural Versus Synthetic Vitamin B Complexes in Human N/A
Enrolling by invitation NCT05389618 - Dietary Challenges in the Population of Nursing Homes' Residents
Completed NCT01832129 - Vitamin B12 Acceptance and Biomarker Response Study Phase 4
Completed NCT03365583 - The Impact of Vitamin B12 Deficiency on Infant Gut Microbiota
Active, not recruiting NCT03071666 - Vitamin B12 Supplementation During Pregnancy on Cognitive Development Phase 2/Phase 3
Active, not recruiting NCT05426395 - Vitamin B12 Dose Escalation Trial in Pregnancy Phase 1
Completed NCT00710138 - Cobalamin Status in Young Children With Developmental Delay N/A
Completed NCT03284840 - Adults Nutrition as a Protective or Health-risk Factor
Not yet recruiting NCT06441721 - Vitamin B12 Status and Its Impact on Chronic Haemodialysis Patient
Completed NCT01476007 - Oral/Intramuscular B12 to Treat Cobalamin Deficiency N/A
Completed NCT03447275 - The Vitamin B Status in Type 2 Diabetes (VITA) Study
Completed NCT02860338 - COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE N/A
Active, not recruiting NCT05178407 - Effect of Household Use of Multiple Micronutrient-fortified Bouillon on Micronutrient Status Among Women and Children in Two Districts in the Northern Region of Ghana N/A